Theodore A. Boutacoff Appointed President & CEO of IRIDEX

Thursday, October 18, 2007 General News J E 4
MOUNTAIN VIEW, Calif., Oct. 17 IRIDEXCorporation (Nasdaq: IRIX) announced today that Barry Caldwell has resigned asthe Company's President and Chief Executive Officer, and as a member of theBoard of Directors, effective as of October 16, 2007. The Board of Directorshas appointed Theodore A. Boutacoff, who is currently a member and Chairman ofthe Board of Directors, to serve as the Company's President and ChiefExecutive Officer. Prior to Mr. Caldwell's two year tenure, Mr. Boutacoff hadbeen the Company's President and Chief Executive Officer since co-founding theCompany in 1989.

"Barry has worked hard during his tenure at IRIDEX," Mr. Boutacoffcommented, "We wish him the best of success in his future endeavors."


IRIDEX Corporation is a leading worldwide provider of therapeutic basedlaser systems, disposable laser probes and delivery devices to treat eyediseases in ophthalmology and skin disorders in the aesthetics market. IRIDEXproducts are sold in the United States through a direct sales force andinternationally through a combination of a direct sales force and a network ofapproximately 97 independent distributors into 107 countries.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Interim Safety Data Favorable for Vical's Phase 2 ...
Cardiac Science Announces Data Connectivity with L...